Laurus Labs Ltd is pleased to announce that the USFDA audit successfully completed without observations - ZERO 483 for its Unit 2 (formulations unit). The inspection was carried out from 26th Feb 2018 - 1st March 2018.
Laurus Labs Ltd has also received its maiden Approval from United States Food and Drug Administration (U.S FDA) for Tenofovir Disoproxil Fumarate Tablets 300mg. Tenofovir Disoproxil Fumarate Tablets 300mg is therapeutically equivalent to VIREAD Tablets 300mg of Gilead Science Ltd. (GILEAD). Tenofovir Disoproxil Fumarate Tablets 300mg is used for treatment of HIV-1 infection in adults and paediatric patients 2 years of age and older.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
